Vericel Corporation (VCEL) Guidance & Earnings Results

On 2026-07-30 Vericel Corporation raised guidance: "FY2026 total revenue raised to $330-340M from $326-336M; MACI revenue raised to $284-290M from $282-288M; Burn Care revenue raised to $46-50M from $44-48M; gross margin ~75% (reaffirmed); adjusted EBITDA margin ~27%…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

VCELVericel CorporationFollow VCEL — free

Biotechnology · Healthcare

—

Price chart with a free account

Market cap: 2.2B
P/E TTM: 90.5
Dividend yield: —
52-week: —
Next earnings: 11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
30 Jul 26	Raised	FY2026 total revenue raised to $330-340M from $326-336M; MACI revenue raised to $284-290M from $282-288M; Burn Care revenue raised to $46-50M from $44-48M; gross margin ~75% (reaffirmed); adjusted EBITDA margin ~27% (reaffirmed) · full year
7 May 26	Raised	FY26 total revenue raised to $326-336M from $316-326M; MACI revenue raised to $282-288M from $280-286M; Burn Care revenue raised to $44-48M from $36-40M; FY26 gross margin ~75% (reaffirmed); FY26 adjusted EBITDA margin ~27% (reaffirmed) · full year
26 Feb 26	Raised	FY2026 total revenue guidance $316-326M (midpoint $321M, ~16% growth vs FY2025 $276.3M); MACI revenue $280-286M; gross margin ~75%; adjusted EBITDA margin ~27% · full year
13 Jan 26	Raised	Total revenue $276M, MACI $239.5M · full year
6 Nov 25	Reaffirmed	Revenue $272-276M, MACI growth low 20%, gross margin 74%, adjusted EBITDA margin 26% · full year
31 Jul 25	Reaffirmed	MACI full-year revenue growth low 20% range; Burn Care H2 2025 revenue ~$10M/quarter; FY gross margin 74%; FY adjusted EBITDA margin 26% · full year

Vericel Corporation — questions

What guidance did Vericel Corporation give?: On 2026-07-30: "FY2026 total revenue raised to $330-340M from $326-336M; MACI revenue raised to $284-290M from $282-288M; Burn Care revenue raised to $46-50M from $44-48M; gross margin ~75% (reaffirmed); adjusted EBITDA margin ~27% (reaffirmed)"
When does Vericel Corporation report earnings?: Vericel Corporation's next earnings report is expected on 2026-11-11.

Every figure on this page comes from Vericel Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.